CompletedNCT06979544
Safety study of Safety and Efficacy of Oral LPCN 1154A in Depression
This study is completed in the United States. It is testing Safety and Efficacy of Oral LPCN 1154A for Depression.
DepressionOtherFrom 15 Years to 45 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
CompletedNCT03818256
Safety study of safety, Efficacy, and Pharmacokinetics of Miricorilant in schizophrenia
This study is completed in the United States. It is testing safety, Efficacy, and Pharmacokinetics of Miricorilant for schizophrenia.
Bipolarity, SchizophreniaOtherFrom 18 Years to 65 Years
CompletedNCT03356639
Safety study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in schizophrenia
This study is completed in the United States. It is testing Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 for schizophrenia.
SchizophreniaOtherFrom 18 Years to 55 Years
CompletedNCT04940039
Treatment of Schizophrenia With Paliperidone Palmitate for schizophrenia
This study is completed in Rwanda. It is testing treatment of Schizophrenia With Paliperidone Palmitate for schizophrenia.
SchizophreniaOtherFrom 19 Years to 34 Years
CompletedNCT02431702
A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform
This study is completed in the United States, in Brazil, and in Mexico. It focuses on schizophrenia.
SchizophreniaOtherFrom 18 Years to 35 Years
CompletedNCT03382639
3 Dose Levels of Luvadaxistat of Adults With Negative Symptoms of Schizophrenia
This study is completed in the United States, in Bulgaria, in Czech Republic, .... It focuses on schizophrenia.
SchizophreniaOtherFrom 18 Years to 60 Years
CompletedNCT00714688
Effectiveness of Effectiveness and Safety of Prolonged Release OROS Methylphenidate in ADHD
This study is completed in France, in the United Kingdom, in Switzerland, .... It is testing Effectiveness and Safety of Prolonged Release OROS Methylphenidate for ADHD.
ADHDOtherFrom 18 Years to 65 Years
WithdrawnNCT05344365
Iloperidone for Schizophrenia
This study has public registry information in the United States. It is testing iloperidone for Schizophrenia.
SchizophreniaOtherOver 65 Years
CompletedNCT04712734
Iloperidone Long-acting Injection (LAI) for schizophrenia
This study is completed in the United States. It is testing Iloperidone Long-acting Injection (LAI) for schizophrenia.
SchizophreniaOtherFrom 18 Years to 65 Years
CompletedNCT03359785
Multiple Oral Doses of Luvadaxistat in Adults With Schizophrenia
This study is completed in the United States. It is testing multiple Oral Doses of Luvadaxistat for schizophrenia.
SchizophreniaOtherFrom 18 Years to 60 Years
CompletedNCT05686239
RL-007 for schizophrenia
This study is completed in the United States, in Bulgaria, in Czech Republic, .... It is testing RL-007 for schizophrenia.
SchizophreniaOtherFrom 18 Years to 55 Years
CompletedNCT05443724
Safety study of CVL-231 (Emraclidine) in schizophrenia
This study is completed in the United States, in Bulgaria, in Hungary, .... It is testing CVL-231 (Emraclidine) for schizophrenia.
SchizophreniaOtherFrom 18 Years to 65 Years